Friday, July 31, 2026

North Korea Tests New Surface-to-Air Missiles, Claims Cruise Missile Interception Capability

North Korea tests new surface-to-air missiles, possibly a clone of the Russian Tor system, showing improved interception capabilities.

That Eye Twitch Might Be More Than Stress—Here’s What to Know

Facial spasms, common in younger adults, may signal neurological issues. Prompt diagnosis and treatment are crucial for quality of life.

Why the Korean Peninsula is Now One of the Top Conflicts to Watch in 2025

The Korean Peninsula is highlighted as a top conflict in 2025, with rising tensions due to North Korea's actions and U.S. political dynamics.

Tag: botulinum toxin

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Hugel Launches Letybo in India: What This Means for the Aesthetic Market in 2026

Hugel enters the Indian market with its botulinum toxin product Letybo, targeting a 9% share in the aesthetic sector this year.

“Automation Alone Isn’t Enough”: Hugel Executive Highlights the Company’s Quality-First Manufacturing Strategy

Hugel's Geodu facility expands botulinum toxin production while prioritizing consistent quality over volume, ensuring global market compliance.

Unlocking the Secrets of Letybo: How Korea’s Leading Botulinum Toxin is Capturing 20% of China’s Market

Hugel successfully held a Letybo symposium in Chengdu, enhancing medical aesthetics knowledge among over 100 Chinese professionals.

Hugel to Showcase Core Aesthetic Portfolio at AMWC Korea as Global Expansion Gains Momentum

Hugel will showcase its aesthetic products at AMWC Korea, featuring Letybo and hosting educational programs and a networking event.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

Hugel holds ‘Letybo’ training in Indonesia to boost competitiveness and brand awareness

Hugel expands in Indonesia with a training program for Letybo, enhancing local medical professionals' skills and brand loyalty.

Hugel holds first regional symposium in Beijing, to tour key cities including Shanghai and Guangzhou

Hugel held a successful symposium in Beijing to enhance awareness of its Letybo product among Chinese medical professionals.

INIBO Launch: How This New Botulinum Toxin is Transforming the Aesthetic Market in Peru

Inibio launched its botulinum toxin product Inibo in Peru, marking a significant entry into the Latin American medical aesthetics market.

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.